Castle Biosciences (CSTL) PT Lowered to $38 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CSTL Hot Sheet
Price: $35.75 +1.74%
Rating Summary:
11 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
11 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
BTIG analyst Sung Ji Nam lowered the price target on Castle Biosciences (NASDAQ: CSTL) to $38.00 (from $43.00) while maintaining a Buy rating.
You May Also Be Interested In
- Siltronic AG (WAF:GR) (SSLLF) PT Raised to EUR123 at UBS
- Mahanagar Gas Limited (MAHGL:IN) PT Lowered to INR1,355 at Nomura/Instinet
- Bayerische Motoren Werke AG (BMW:GR) (BMWYY) PT Lowered to EUR66 at HSBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
